journal article·2022-03-14

Surface Self-Assembly Construction of Therapeutic Contact Lens with Bacterial “Kill-Releasing” and Drug-Reloading Capabilities for Efficient Bacterial Keratitis Treatment

Shimin Wen, Chen Qin, Liangliang Shen, Dong Liu, Siqing Zhu, Quankui Lin

Publisher page

Abstract

Bacterial keratitis, an ophthalmic emergency, can cause corneal perforation and even endophthalmitis, thus leading to severe visual impairment. To achieve effective treatment of bacterial keratitis, good bioavailability of antimicrobial drugs on the ocular surface is desired. In this investigation, a layer-by-layer (LBL) self-assembly combined with the host–guest recognition was used to construct an antibacterial coating on the surface of corneal contact lens (CLs) to improve drug bioavailability and achieve successful treatment of bacterial keratitis. First, a radical copolymerization of acrylic acid (AA) and 1-adamantan-1-ylmethyl acrylate (AdA) was carried out to synthesize a polyanionic copolymer P(AA-co-AdA) (defined as PAcA). Then, PAcA copolymer combined with poly(ethyleneimine) (PEI) was used for a layer-by-layer (LBL) self-assembly to fabricate multilayer films on the surface of CLs. An antibacterial conjugate, β-cyclodextrin–levofloxacin (β-CD-LEV), was successfully synthesized and utilized to generate antibacterial coating through a host–guest interaction between AdA and β-CD-LEV. The antibacterial ability and treatment effect of bacterial keratitis was evaluated by in vitro assay and in vivo test in an animal model of staphylococcal keratitis, demonstrating that the antibacterial coating had good antibacterial and germicidal efficacy both in vivo and in vitro. We believe that this work will provide a promising strategy for the treatment of bacterial keratitis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ocular Surface and Contact Lens · Ocular Infections and Treatments · Intraocular Surgery and Lenses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomaterials, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China

Funding

Medical and Health Research Project of Zhejiang Province · Zhejiang Science and Technology Program of Traditional Chinese Medicine · Key Scientific and Technological Innovation Projects in Wenzhou

References (52)

Show source-provided references
1. 10.3390/proteomes304049610.3390/proteomes3040496 ↗
2. Limberg M. B. · Am. J. Ophthalmol. · 1991 · 112 · 2S
3. 10.3390/cells911245010.3390/cells9112450 ↗
4. 10.7883/yoken.JJID.2018.26910.7883/yoken.JJID.2018.269 ↗
5. 10.1038/s41598-021-97821-310.1038/s41598-021-97821-3 ↗
6. 10.3390/ma1107112510.3390/ma11071125 ↗
7. 10.3390/pharmaceutics1304045210.3390/pharmaceutics13040452 ↗
8. 10.3390/nano1006119110.3390/nano10061191 ↗
9. 10.3390/pharmaceutics1304044710.3390/pharmaceutics13040447 ↗
10. 10.1016/j.ijpharm.2021.12101210.1016/j.ijpharm.2021.121012 ↗
11. 10.3390/nano1109232810.3390/nano11092328 ↗
12. 10.3390/molecules2618557710.3390/molecules26185577 ↗
13. 10.1016/j.coche.2021.10072710.1016/j.coche.2021.100727 ↗
14. 10.3390/mi1209111110.3390/mi12091111 ↗
15. 10.1016/j.colsurfb.2021.11209610.1016/j.colsurfb.2021.112096 ↗
16. 10.1167/iovs.12-1061410.1167/iovs.12-10614 ↗
17. 10.1167/iovs.14-1485510.1167/iovs.14-14855 ↗
18. 10.1021/acsbiomaterials.7b0097710.1021/acsbiomaterials.7b00977 ↗
19. 10.7150/thno.4541310.7150/thno.45413 ↗
20. 10.1002/jps.2453710.1002/jps.24537 ↗
21. 10.1016/j.biomaterials.2017.01.04610.1016/j.biomaterials.2017.01.046 ↗
22. 10.1021/acsami.7b1356510.1021/acsami.7b13565 ↗
23. 10.1021/acsami.9b1758110.1021/acsami.9b17581 ↗
24. 10.11777/j.issn1000-3304.2020.2003110.11777/j.issn1000-3304.2020.20031 ↗
25. 10.1002/adhm.20180138110.1002/adhm.201801381 ↗
26. 10.1039/d0bm00617c10.1039/d0bm00617c ↗
27. 10.1016/j.jmst.2020.07.02810.1016/j.jmst.2020.07.028 ↗
28. 10.7150/thno.3165310.7150/thno.31653 ↗
29. 10.1021/ar500105t10.1021/ar500105t ↗
30. 10.1039/c7cs00391a10.1039/c7cs00391a ↗
31. 10.1039/d0tb02802a10.1039/d0tb02802a ↗
32. 10.1021/cr400531v10.1021/cr400531v ↗
33. 10.3390/ma1208120610.3390/ma12081206 ↗
34. 10.1016/j.biomaterials.2020.11992910.1016/j.biomaterials.2020.119929 ↗
35. 10.1021/acsabm.0c0033110.1021/acsabm.0c00331 ↗
36. 10.1080/09205063.2020.186569110.1080/09205063.2020.1865691 ↗
37. 10.1016/j.colcom.2018.03.00710.1016/j.colcom.2018.03.007 ↗
38. 10.1016/j.ijpharm.2020.11950610.1016/j.ijpharm.2020.119506 ↗
39. 10.1039/d1ra02472h10.1039/d1ra02472h ↗
40. 10.1016/j.carbpol.2019.11547910.1016/j.carbpol.2019.115479 ↗
41. 10.1111/vop.1269310.1111/vop.12693 ↗
42. 10.1038/s41467-018-06623-110.1038/s41467-018-06623-1 ↗
43. 10.1021/jp050140110.1021/jp0501401 ↗
44. 10.1021/la403774810.1021/la4037748 ↗
45. 10.1021/acsami.6b1118710.1021/acsami.6b11187 ↗
46. 10.1007/s13233-009-0120-110.1007/s13233-009-0120-1 ↗
47. 10.2147/IJN.S21580210.2147/IJN.S215802 ↗
48. 10.1080/00914037.2016.119092510.1080/00914037.2016.1190925 ↗
49. 10.1016/j.cej.2021.13271610.1016/j.cej.2021.132716 ↗
50. 10.1016/j.cej.2021.13155310.1016/j.cej.2021.131553 ↗
51. 10.1167/tvst.9.3.1310.1167/tvst.9.3.13 ↗
52. 10.1039/c6tb02821g10.1039/c6tb02821g ↗